本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enliven Treateutics

26.00
+2.7511.83%
盘后26.120.1200+0.46%19:58 EST
成交量:578.65万
成交额:1.55亿
市值:15.43亿
市盈率:-14.33
高:29.98
开:23.58
低:23.27
收:23.25
52周最高:29.98
52周最低:13.30
股本:5,934.73万
流通股本:3,499.96万
量比:2.47
换手率:16.53%
股息:- -
股息率:- -
每股收益(TTM):-1.8147
每股收益(LYR):-1.8912
净资产收益率:-25.43%
总资产收益率:-17.62%
市净率:3.24
市盈率(LYR):-13.75

数据加载中...

2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

重要事件披露

Form 8-K - Current report
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/11/12

重要事件披露

Form 8-K - Current report
2025/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities